Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phosphorothioate-Free and Self-Interaction-Reduced Acyclic Nucleic Acids for Effective Antisense Oligonucleotide.

Journal of medicinal chemistry·2026

Same author

Bioinformatic Prediction of Activation States in Molecular Network Pathways of Eukaryotic Initiation Factor 2 (EIF2) Signaling and Coronavirus Pathogenesis.

International journal of molecular sciences·2026

Same author

Author Correction: Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer.

Nature biomedical engineering·2026

Same author

Adverse Outcome Pathway 298: Increase in Reactive Oxygen Species Leading to Human Treatment-Resistant Gastric Cancer.

Cancers·2026

Same author

Peer Review and AI: Your (Human) Opinion Is What Matters.

ACS nano·2026

Same author

Overcoming barriers: nanomedicine-based strategies for nose-to-brain delivery.

Nanoscale·2025

Search research articles

Related Experiment Video

Updated: Mar 2, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Nanomaterial-Enabled Cancer Therapy.

Sabina Quader¹, Kazunori Kataoka²

¹Innovation Center of Nanomedicine, Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki 212-0821, Japan.

Molecular Therapy : the Journal of the American Society of Gene Therapy

|May 24, 2017

Summary

This summary is machine-generated.

Nanomaterials (NM) offer promising cancer diagnosis and treatment by targeting tumors and improving drug delivery. However, tumor heterogeneity and pre-clinical study discrepancies hinder clinical translation.

Keywords:

cancer clinical translation combination therapy nanomaterial polyplex pre-clinical therapy tumor heterogeneity

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Related Experiment Videos

Last Updated: Mar 2, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Area of Science:

Oncology
Nanotechnology
Biomedical Engineering

Background:

Cancer is a leading global cause of death.
Nanomaterials (NM) show potential in cancer diagnosis and treatment.
NM can target tumors, enhance drug bioavailability, and reduce toxicity.

Purpose of the Study:

Review recent research on NM in cancer therapy and imaging.
Discuss challenges in translating NM-based cancer therapies to clinical practice.
Propose strategies to overcome translational barriers.

Main Methods:

Literature review of recent studies on NM for cancer.
Analysis of NM applications in cancer therapy and imaging.
Discussion on tumor heterogeneity and pre-clinical vs. clinical study disparities.

Main Results:

NM can deliver therapeutic agents, imaging contrast agents, and genetic materials.
NM enable combination therapy and theranostic applications.
Tumor heterogeneity and translational gaps are significant challenges.

Conclusions:

NM hold significant promise for advancing cancer care.
Addressing tumor heterogeneity and translational challenges is crucial for clinical success.
Further research is needed to bridge the gap between pre-clinical findings and clinical application.